Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01A
- Chemical subgroupL01AD
- Chemical substanceL01AD02Lomustine
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 3 registrations
Netherlands
CBG-MEB · 2 registrations
United States
FDA · 2 registrations
At a glance
- ATC code
- L01AD02
- Registers
- 6
- Registrations
- 10
- With their own page
- 7
- Companies
- 8
All medicines with Lomustine
Human medicines from every register that match Lomustine by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
10 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Lomustine | United States | 100MG, 10MG, 40MG | capsule | Marketed | Carnegie |
| Lomustine BModesto capsules, hard 40 mg | Netherlands | Capsule, hard | Authorised | BModesto B.V. | |
| Lomustine Eureco-Pharma, capsules, hard 40 mg | Netherlands | Capsule, hard | Authorised | Eureco-Pharma B.V. | |
| Gleostine | United States | 100MG, 10MG, 40MG … | capsule | Marketed | Azurity |
| Ceenu | Canada | 40 MG | Capsule | Marketed | Septa Pharmaceuticals INC |
| Ceenu | Canada | 10 MG | Capsule | Marketed | Septa Pharmaceuticals INC |
| Medac | New Zealand | Cap 40 mg | Funded | ||
| Belustine Capsulas | Spain | 40 mg | cápsula dura | Withdrawn | Bellon |
| Ceenu | Canada | 100 MG | Capsule | Cancelled | Bristol-Myers Squibb Canada |
| Citostal | Brazil | Cancelled | Bristol-Myers Squibb Farmacêutica Ltda |